Jin-Ming Zhou (Jinming Zhou)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 19

Top Topics

Benign Prostatic Hyperplasia

Prostate Cancer

Top Venues

Molecules (Basel, Switzerland)

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Jieke Gao, Yongli Xie, Jiantao Zhang, Huirong Chen, Yan Zou, Shan Cen, Jin-Ming Zhou
A novel hydrophobic tag leads to the efficient degradation of programmed death-ligand 1. RSC medicinal chemistry 15 (9) (2024)
Chenfan Li, Xiaoli Han, Qiuxia Yan, Yang Ji, Rongyu Zhang, Dazhong Yuan, Fulian Yang, Jianlong Wang, Meng Wu, Jin-Ming Zhou
Design and Synthesis of Dual-Target Inhibitors Targeting Androgen Receptors and Glucocorticoid Receptors to Overcome Antiandrogen Resistance in Castration-Resistant Prostate Cancer. Journal of medicinal chemistry 67 (5) (2024)
Chenfan Li, Xiaoli Han, Qiuxia Yan, Yang Ji, Rongyu Zhang, Dazhong Yuan, Fulian Yang, Jianlong Wang, Meng Wu, Jin-Ming Zhou
Design and Synthesis of Dual-Target Inhibitors Targeting Androgen Receptors and Glucocorticoid Receptors to Overcome Antiandrogen Resistance in Castration-Resistant Prostate Cancer. Journal of medicinal chemistry (2024)
Chenfan Li, Xiaoli Han, Qiuxia Yan, Yang Ji, Rongyu Zhang, Dazhong Yuan, Fulian Yang, Jianlong Wang, Meng Wu, Jin-Ming Zhou
Design and Synthesis of Dual-Target Inhibitors Targeting Androgen Receptors and Glucocorticoid Receptors to Overcome Antiandrogen Resistance in Castration-Resistant Prostate Cancer. Journal of medicinal chemistry 67 (5) (2024)
Meng Wu, Rongyu Zhang, Zixiong Zhang, Ning Zhang, Chenfan Li, Yongli Xie, Haoran Xia, Fangjiao Huang, Ruoying Zhang, Ming Liu, Xiaoyu Li, Shan Cen, Jin-Ming Zhou
Selective androgen receptor degrader (SARD) to overcome antiandrogen resistance in castration-resistant prostate cancer. eLife 12 (2023)
Meng Wu, Rongyu Zhang, Zixiong Zhang, Ning Zhang, Chenfan Li, Yongli Xie, Haoran Xia, Fangjiao Huang, Ruoying Zhang, Ming Liu, Xiaoyu Li, Shan Cen, Jin-Ming Zhou
Selective androgen receptor degrader (SARD) to overcome antiandrogen resistance in castration-resistant prostate cancer. eLife 12 (2023)
Xile Zhou, Yang Ji, Jin-Ming Zhou
Multiple Strategies to Develop Small Molecular KRAS Directly Bound Inhibitors. Molecules (Basel, Switzerland) 28 (8) (2023)
Meng Wu, Rongyu Zhang, Zixiong Zhang, Ning Zhang, Chenfan Li, Yongli Xie, Haoran Xia, Fangjiao Huang, Ruoying Zhang, Ming Liu, Xiaoyu Li, Shan Cen, Jin-Ming Zhou
Selective androgen receptor degrader (SARD) to overcome antiandrogen resistance in castration-resistant prostate cancer. eLife 12 (2023)
Xile Zhou, Yang Ji, Jin-Ming Zhou
Multiple Strategies to Develop Small Molecular KRAS Directly Bound Inhibitors. Molecules (Basel, Switzerland) 28 (8) (2023)
Xile Zhou, Yang Ji, Jin-Ming Zhou
Multiple Strategies to Develop Small Molecular KRAS Directly Bound Inhibitors. Molecules (Basel, Switzerland) 28 (8) (2023)
Xile Zhou, Yang Ji, Jin-Ming Zhou
Multiple Strategies to Develop Small Molecular KRAS Directly Bound Inhibitors. Molecules (Basel, Switzerland) 28 (8) (2023)
Meng Wu, Rongyu Zhang, Zixiong Zhang, Ning Zhang, Chenfan Li, Yongli Xie, Haoran Xia, Fangjiao Huang, Ruoying Zhang, Ming Liu, Xiaoyu Li, Shan Cen, Jin-Ming Zhou
Selective androgen receptor degrader (SARD) to overcome antiandrogen resistance in castration-resistant prostate cancer. eLife 12 (2023)
Xile Zhou, Qianqian Han, Jin-Ming Zhou, Chaoxu Liu, Ji Yang Liu
Reagentless Electrochemical Detection of Tumor Biomarker Based on Stable Confinement of Electrochemical Probe in Bipolar Silica Nanochannel Film. Nanomaterials (Basel, Switzerland) 13 (10) (2023)
Meng Wu, Rongyu Zhang, Zixiong Zhang, Ning Zhang, Chenfan Li, Yongli Xie, Haoran Xia, Fangjiao Huang, Ruoying Zhang, Ming Liu, Xiaoyu Li, Shan Cen, Jin-Ming Zhou
Selective androgen receptor degrader (SARD) to overcome antiandrogen resistance in castration-resistant prostate cancer. eLife 12 (2023)
Fangjiao Huang, Xiaoli Han, Xiaohui Xiao, Jin-Ming Zhou
Covalent Warheads Targeting Cysteine Residue: The Promising Approach in Drug Development. Molecules (Basel, Switzerland) 27 (22) (2022)
Xiangling Cui, Yongli Xie, Min Zhang, Jieke Gao, Xujun Zhou, Jiwei Ding, Shan Cen, Jin-Ming Zhou
Identification of Ziyuglycoside II from a Natural Products Library as a STING Agonist. ChemMedChem 17 (11) (2022)
Ling Ma, Jiajia Wen, Biao Dong, Jin-Ming Zhou, Shangjiu Hu, Juxian Wang, Yucheng Wang, Mei Zhu, Shan Cen
Design and Evaluation of Novel HIV-1 Protease Inhibitors Containing Phenols or Polyphenols as P2 Ligands with High Activity against DRV-Resistant HIV-1 Variants. International journal of molecular sciences 23 (22) (2022)
Jin-Ming Zhou, Jian Hui Wu
Binding-Site Match Maker (BSMM): A Computational Method for the Design of Multi-Target Ligands. Molecules (Basel, Switzerland) 25 (8) (2020)
Yong-Xin Zhang, Yu-Ming Huang, Quan-Jie Li, Xiao-Yu Li, Yong-Dong Zhou, Fei Guo, Jin-Ming Zhou, Shan Cen
A highly conserved amino acid in VP1 regulates maturation of enterovirus 71. PLoS pathogens 13 (9) (2017)